HAILEY Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hailey, and when can generic versions of Hailey launch?
Hailey is a drug marketed by Glenmark Speclt and Glenmark Pharms Ltd and is included in four NDAs.
The generic ingredient in HAILEY is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HAILEY?
- What are the global sales for HAILEY?
- What is Average Wholesale Price for HAILEY?
Summary for HAILEY
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for HAILEY |
| DailyMed Link: | HAILEY at DailyMed |
US Patents and Regulatory Information for HAILEY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | HAILEY 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 209297-001 | Jun 5, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Pharms Ltd | HAILEY FE 1/20 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 206597-001 | Nov 21, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Pharms Ltd | HAILEY 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 204847-001 | Nov 17, 2017 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Speclt | HAILEY FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 209031-001 | Jun 5, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
